Nathan Cheng's guest appearances

Nathan Cheng

Village Global's Venture Stories

POD OF JAKE

Translating Aging

Josh Clemente

Elad Gil

Austen Allred

Haseeb Qureshi

Kendrick Nguyen

Ryan Delk

Danielle Strachman

Julia Galef

Jude Gomila

Nikhil Basu Trivedi

Mike Elias

Steve Schlafman

Patri Friedman

Keith Rabois

Daniel Gross

OwlTail

On today’s episode of Translating Aging, Chris welcomes Nathan Cheng, the program director at On Deck Longevity Biotech (ODLB), to discuss how ODLB is cultivating new founders and connecting people in the longevity biotech space. Nathan writes about the longevity biotech industry in his Longevity Marketcap Newsletter, is the founder of Longevity List which aims to connect job seekers, companies and investors in the longevity industry, and is on a self-professed mission to end biological aging, Today, he tells us about the purpose of ODLB, its achievements thus far, and the bridge it hopes to build in the longevity biotech industry.Nathan begins the conversation by discussing what On Deck is and why the company was formed. He briefly narrates his journey in tech, what increased his interest in the longevity space, and the mission of the ODLB, as well as how the fellowship works towards creating founders. He goes on to discuss the obstacles many face when they get accepted in the fellowship and how ODLB works to reduce those obstacles by promoting face-to-face interactions. Also contained in this episode are brief interviews with ODLB fellows Brian Hodge and Gabe Warshauer-Baker.Episode Highlights:What is On Deck? Nathan’s journey in the longevity space On Deck Longevity Biotech’s (ODLB) mission The importance of connecting those in the longevity biotech space How mentors contribute in ODLB Does the startup culture reward extroverts over introverts? Getting into the ODLB fellowship Interviews with ODLB fellows Feats the ODLB has achieved The future of the longevity biotech spaceQuotes:“At a high level, On Deck is where people come to start and accelerate their companies. It's also a place where people start and accelerate their careers in the startup economy.”“What makes On Deck unique is that it's a huge network of interconnected program communities. So we have communities centered around specific career goals.”“ODLB’s mission is to increase the number of people working to build longevity biotech startups.”“For some people coming from the scientific domain, this whole idea of networking is foreign to them or nebulous.”“We're gonna generate new founders, but among the people who decide for whatever reason not to become founders, we also want them to be encouraged and empowered to be involved in longevity biotech in some other capacity.”“Putting ourselves on the map for people who are interested in building longevity biotech, I think that is our greatest achievement so far. ”“So I think just more efforts in popularizing this geroscience paradigm, you know, actually targeting aging, I think there's a lot to be done there as well.”Links:Email questions, comments, and feedback to podcast@bioagelabs.comTranslating Aging on Twitter: @bioagepodcastBIOAGE Labs Website BIOAGELabs.comBIOAGE Labs Twitter @bioagelabsBIOAGE Labs LinkedInOn Deck Longevity Biotech WebsiteNathan Cheng Twitter

On today’s episode of Translating Aging, Chris welcomes Nathan Cheng, the program director at On Deck Longevity Biotech (ODLB), to discuss how ODLB is cultivating new founders and connecting people in the longevity biotech space. Nathan writes about the longevity biotech industry in his Longevity Marketcap Newsletter, is the founder of Longevity List which aims to connect job seekers, companies and investors in the longevity industry, and is on a self-professed mission to end biological aging, Today, he tells us about the purpose of ODLB, its achievements thus far, and the bridge it hopes to build in the longevity biotech industry.Nathan begins the conversation by discussing what On Deck is and why the company was formed. He briefly narrates his journey in tech, what increased his interest in the longevity space, and the mission of the ODLB, as well as how the fellowship works towards creating founders. He goes on to discuss the obstacles many face when they get accepted in the fellowship and how ODLB works to reduce those obstacles by promoting face-to-face interactions. Also contained in this episode are brief interviews with ODLB fellows Brian Hodge and Gabe Warshauer-Baker.Episode Highlights:<ul><li>What is On Deck?</li><li> </li><li>Nathan’s journey in the longevity space</li><li> </li><li>On Deck Longevity Biotech’s (ODLB) mission</li><li> </li><li>The importance of connecting those in the longevity biotech space</li><li> </li><li>How mentors contribute in ODLB</li><li> </li><li>Does the startup culture reward extroverts over introverts?</li><li> </li><li>Getting into the ODLB fellowship</li><li> </li><li>Interviews with ODLB fellows</li><li> </li><li>Feats the ODLB has achieved</li><li> </li><li>The future of the longevity biotech space</li></ul>Quotes:“At a high level, On Deck is where people come to start and accelerate their companies. It's also a place where people start and accelerate their careers in the startup economy.”“What makes On Deck unique is that it's a huge network of interconnected program communities. So we have communities centered around specific career goals.”“ODLB’s mission is to increase the number of people working to build longevity biotech startups.”“For some people coming from the scientific domain, this whole idea of networking is foreign to them or nebulous.”“We're gonna generate new founders, but among the people who decide for whatever reason not to become founders, we also want them to be encouraged and empowered to be involved in longevity biotech in some other capacity.”“Putting ourselves on the map for people who are interested in building longevity biotech, I think that is our greatest achievement so far. ”“So I think just more efforts in popularizing this geroscience paradigm, you know, actually targeting aging, I think there's a lot to be done there as well.”Links:Email questions, comments, and feedback to podcast@bioagelabs.comTranslating Aging on Twitter:<a href="https://twitter.com/BioAgePodcast" rel="noopener noreferrer nofollow" target="_blank"> @bioagepodcast</a>BIOAGE Labs Website<a href="https://bioagelabs.com/" rel="noopener noreferrer nofollow" target="_blank"> BIOAGELabs.com</a>BIOAGE Labs Twitter<a href="https://twitter.com/bioagelabs?lang=en" rel="noopener noreferrer nofollow" target="_blank"> @bioagelabs</a>BIOAGE Labs<a href="https://www.linkedin.com/company/bioage-labs/" rel="noopener noreferrer nofollow" target="_blank"> LinkedIn</a>On Deck Longevity Biotech<a href="https://www.beondeck.com/longevity-biotech/" rel="noopener noreferrer nofollow" target="_blank"> Website</a>Nathan Cheng<a href="https://twitter.com/realNathanCheng" rel="noopener noreferrer nofollow" target="_blank"> Twitter</a>

Building Community in the Longevity Biotech Space (Nathan Cheng)

Nathan Cheng (@realNathanCheng), program director for On Deck Longevity, joins Erik on this episode to discuss:- The key breakthroughs in aging research in the past.- Why we're still waiting for the first success story in humans, and why he predicts the first drug will be approved in the next ten years.- Why the space has plenty of capital but not enough founders.- The challenges and roadblocks in the space.- Common misconceptions about longevity.- Who should think about applying to the program.Thanks for listening — if you like what you hear, please review us on your favorite podcast platform. Check us out on the web at www.villageglobal.vc or get in touch with us on Twitter @villageglobal.Want to get updates from us? Subscribe to get a peek inside the Village. We’ll send you reading recommendations, exclusive event invites, and commentary on the latest happenings in Silicon Valley. www.villageglobal.vc/signup

Nathan Cheng (@realNathanCheng), program director for On Deck Longevity, joins Erik on this episode to discuss: - The key breakthroughs in aging research in the past. - Why we're still waiting for the first success story in humans, and why he predicts the first drug will be approved in the next ten years. - Why the space has plenty of capital but not enough founders. - The challenges and roadblocks in the space. - Common misconceptions about longevity. - Who should think about applying to the program. Thanks for listening — if you like what you hear, please review us on your favorite podcast platform.  Check us out on the web at <a href="http://www.villageglobal.vc" rel="noopener nofollow" target="_blank">www.villageglobal.vc</a> or get in touch with us on Twitter @villageglobal. Want to get updates from us? Subscribe to get a peek inside the Village. We’ll send you reading recommendations, exclusive event invites, and commentary on the latest happenings in Silicon Valley. <a href="http://www.villageglobal.vc/signup" rel="noopener nofollow" target="_blank">www.villageglobal.vc/signup</a>

The State and Future of Longevity with Nathan Cheng

Nathan is an entrepreneur, longevity biotechnology advocate, and investor based in Toronto. He is the creator of Longevity List, Longevity Marketcap, and Biohack Stack. He also writes the Longevity Marketcap Newsletter — a weekly review of developments in the longevity industry. Nathan is a former Quantum Optics Ph.D candidate on a mission to end biological aging. Follow him on Twitter @realNathanCheng. [0:59] - How Nathan's existential crisis pushed him to focus on longevity [9:55] - Confronting death and contemplating life's purpose while traveling the world [22:30] - The evolution of Nathan's involvement in the longevity space [32:57] - Nathan's strategy to explain the importance of longevity technology [40:20] - Reasons for increasing attention on longevity research [47:07] - How anyone can contribute to the longevity movement [50:54] - Promising solutions under development today [57:57] - Nathan's personal strategies to live longer [1:06:37] - Nathan answer to the question, "how long do you expect to live?" --- homeofjake.com

Nathan is an entrepreneur, longevity biotechnology advocate, and investor based in Toronto. He is the creator of <a href="https://longevitylist.com/" rel="nofollow" target="_blank">Longevity List,</a> <a href="https://longevitymarketcap.com/" rel="nofollow" target="_blank">Longevity Marketcap</a>, and <a href="https://biohackstack.com/" rel="nofollow" target="_blank">Biohack Stack</a>. He also writes the <a href="https://longevitymarketcap.substack.com/" rel="nofollow" target="_blank">Longevity Marketcap Newsletter</a> — a weekly review of developments in the longevity industry. Nathan is a former Quantum Optics Ph.D candidate on a mission to end biological aging. Follow him on Twitter <a href="https://twitter.com/realNathanCheng" rel="nofollow" target="_blank">@realNathanCheng</a>. [0:59] - How Nathan's existential crisis pushed him to focus on longevity [9:55] - Confronting death and contemplating life's purpose while traveling the world [22:30] - The evolution of Nathan's involvement in the longevity space [32:57] - Nathan's strategy to explain the importance of longevity technology [40:20] - Reasons for increasing attention on longevity research [47:07] - How anyone can contribute to the longevity movement [50:54] - Promising solutions under development today [57:57] - Nathan's personal strategies to live longer [1:06:37] - Nathan answer to the question, "how long do you expect to live?" --- <a href="https://homeofjake.com/" rel="nofollow" target="_blank">homeofjake.com</a>

#59 - NATHAN CHENG